2 results
21/Nov/2022
DOI: 10.31744/einstein_journal/2022RW0045
ABSTRACT Objective We performed a systematic review of the literature and meta-analysis on the efficacy and safety of hydroxychloroquine to treat COVID-19 patients. Methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and LILACS (January 2019 to March 2021) for patients aged 18 years or older, who had COVID-19 and were treated with hydroxychloroquine versus placebo or standard of care. We also searched the WHO Clinical Trials Registry for ongoing and recently completed studies, and the […]
Keywords: Coronavirus infections; COVID-19; Disease prevention; Drug-related side effects and adverse reactions; Hydroxychloroquine; SARS-CoV-2; Therapeutics
02/Feb/2022
DOI: 10.31744/einstein_journal/2022AO6153
ABSTRACT Objective To estimate the prevalence of clustering of behavioral risk factors for chronic non-communicable diseases, as well as the associated factors in climacteric women. Methods This is a cross-sectional, analytical study, with random selection of climacteric women, aged between 40 and 65 years, and registered in Family Health Strategy units. The dependent variable was clustering of three or more behavioral risk factors for chronic non-communicable diseases. The definition of associated variables was made after Poisson multiple regression analysis with […]
Keywords: Climacteric; Disease prevention; Health Behavior; Noncommunicable diseases; Obesity; Risk Factors; Women; Women’s health